Q32 Bio Newsroom

Positive Outlook for Q32 Bio: Buy Rating Backed by Promising Clinical Timelines and Increased Price Target

TipRanksNov 11 14:31

Wells Fargo Maintains Q32 Bio(QTTB.US) With Buy Rating, Maintains Target Price $95

Futu NewsNov 5 18:40

Oppenheimer Maintains Q32 Bio(QTTB.US) With Buy Rating, Raises Target Price to $80

Futu NewsOct 16 20:31

Q32 Bio Analyst Ratings

BenzingaSep 11 20:54

Wells Fargo Initiates Q32 Bio at Overweight With $95 Price Target

MT NewswiresSep 11 19:35

Wells Fargo Initiates Q32 Bio(QTTB.US) With Buy Rating, Announces Target Price $95

Futu NewsSep 11 18:33

Piper Sandler Maintains Q32 Bio(QTTB.US) With Buy Rating, Maintains Target Price $60

Futu NewsAug 23 19:33

Piper Sandler Sticks to Their Buy Rating for Q32 Bio (QTTB)

TipRanksAug 23 19:09

Piper Sandler Maintains Q32 Bio(QTTB.US) With Buy Rating, Raises Target Price to $60

Futu NewsAug 19 19:31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB)

TipRanksAug 19 19:05

Analysts Are Bullish on These Healthcare Stocks: Q32 Bio (QTTB), Wave Life Sciences (WVE)

TipRanksAug 13 22:20

Buy Rating on Q32 Bio: Promising Clinical Trials and Market Potential for Bempikibart

TipRanksJul 26 14:02

Piper Sandler Maintains Q32 Bio(QTTB.US) With Buy Rating, Maintains Target Price $45

Futu NewsJul 25 19:34

Q32 Bio (QTTB) Receives a Buy From Piper Sandler

TipRanksJul 25 18:55

Q32 Bio (QTTB) Receives a Rating Update From a Top Analyst

TipRanksJul 12 15:19

Guggenheim Initiates Coverage On Q32 Bio With Buy Rating, Announces Price Target of $100

BenzingaJun 17 19:13

Q32 Bio Analyst Ratings

BenzingaJun 17 19:12

Q32 Bio (QTTB.US) was first covered by Leerink Partners, which gave it an superior market rating, with a target price of $54.00.

Zhitong FinanceMay 21 21:03

Q32 Bio Analyst Ratings

BenzingaMay 21 21:00

Leerink Partners Initiates Coverage On Q32 Bio With Outperform Rating, Announces Price Target of $54

BenzingaMay 21 21:00